Mario Ghosn

483 total citations
39 papers, 305 citations indexed

About

Mario Ghosn is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mario Ghosn has authored 39 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Mario Ghosn's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Renal cell carcinoma treatment (6 papers) and Testicular diseases and treatments (6 papers). Mario Ghosn is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Renal cell carcinoma treatment (6 papers) and Testicular diseases and treatments (6 papers). Mario Ghosn collaborates with scholars based in France, United States and Lebanon. Mario Ghosn's co-authors include Stephen B. Solomon, Christine Théodore, M Ostronoff, D Baume, J P Droz, A. Kramar, J. L. Pico, Jean‐Pierre Droz, G. Piot and M. Spielmann and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Mario Ghosn

36 papers receiving 296 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Ghosn France 10 150 86 73 64 55 39 305
C Théodore France 11 178 1.2× 121 1.4× 134 1.8× 81 1.3× 77 1.4× 28 353
Jonathan Rock United States 12 163 1.1× 47 0.5× 186 2.5× 42 0.7× 44 0.8× 15 373
Pedro de Agustín Spain 11 111 0.7× 76 0.9× 66 0.9× 32 0.5× 37 0.7× 27 294
H Schefer Switzerland 6 78 0.5× 57 0.7× 141 1.9× 38 0.6× 54 1.0× 14 336
Claudio Graiff Italy 12 78 0.5× 120 1.4× 166 2.3× 26 0.4× 49 0.9× 16 327
Rei Noguchi Japan 11 130 0.9× 227 2.6× 156 2.1× 17 0.3× 126 2.3× 74 446
Subhash C. Gulati United States 7 99 0.7× 89 1.0× 134 1.8× 114 1.8× 42 0.8× 12 380
Shinsuke Shibuya Japan 11 101 0.7× 125 1.5× 140 1.9× 43 0.7× 75 1.4× 40 402
Vogelzang Nj United States 9 248 1.7× 114 1.3× 106 1.5× 103 1.6× 103 1.9× 12 436
Atsushi Iida Japan 10 209 1.4× 148 1.7× 80 1.1× 19 0.3× 57 1.0× 43 353

Countries citing papers authored by Mario Ghosn

Since Specialization
Citations

This map shows the geographic impact of Mario Ghosn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Ghosn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Ghosn more than expected).

Fields of papers citing papers by Mario Ghosn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Ghosn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Ghosn. The network helps show where Mario Ghosn may publish in the future.

Co-authorship network of co-authors of Mario Ghosn

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Ghosn. A scholar is included among the top collaborators of Mario Ghosn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Ghosn. Mario Ghosn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghosn, Mario, et al.. (2025). End of Pandemic Parental Hesitancy Towards Pediatric COVID-19 Vaccination: A Cross-sectional Survey at Two Lebanese Tertiary Hospitals. Journal of Epidemiology and Global Health. 15(1). 15–15.
2.
Pescatori, Lorenzo, Mario Ghosn, Maxime Blain, et al.. (2024). Combination of intrahepatic TARE and extrahepatic TACE to treat HCC patients with extrahepatic artery supply: A case series. SHILAP Revista de lepidopterología. 9. 100042–100042. 1 indexed citations
3.
Ghosn, Mario, Lambros Tselikas, Stéphane Champiat, et al.. (2023). Intratumoral Immunotherapy: Is It Ready for Prime Time?. Current Oncology Reports. 25(8). 857–867. 10 indexed citations
4.
Mulé, Sebastien, Maxime Ronot, Mario Ghosn, et al.. (2023). Automated CT LI-RADS v2018 scoring of liver observations using machine learning: A multivendor, multicentre retrospective study. JHEP Reports. 5(10). 100857–100857. 7 indexed citations
5.
Ghosn, Mario, Elena N. Petre, Tuomas Tammela, et al.. (2023). Induction and preliminary characterization of neoplastic pulmonary nodules in a transgenic pig model. Lung Cancer. 178. 157–165. 6 indexed citations
6.
Jugnon, Vincent, et al.. (2022). How to Register a Live onto a Liver ? Partial Matching in the Space of Varifolds. 1(IPMI 2021). 1–30. 1 indexed citations
7.
Ridouani, Fourat, Mario Ghosn, Adrian J. Gonzalez‐Aguirre, et al.. (2022). Accuracy of a CBCT-based virtual injection software for vessel detection during hepatic arterial embolization. European Journal of Radiology. 150. 110273–110273. 1 indexed citations
8.
Ghosn, Mario, Fourat Ridouani, Kevin Royalty, et al.. (2022). Augmented fluoroscopy guided transbronchial pulmonary microwave ablation using a steerable sheath. Translational Lung Cancer Research. 11(2). 150–164. 7 indexed citations
9.
Petre, Elena N., Fourat Ridouani, Mario Ghosn, et al.. (2022). Percutaneous Image-Guided Biopsy for a Comprehensive Hybridization Capture-Based Next-Generation Sequencing in Primary Lung Cancer: Safety, Efficacy, and Predictors of Outcome. JTO Clinical and Research Reports. 3(6). 100342–100342. 2 indexed citations
10.
Ghosn, Mario, T. Peter Kingham, Fourat Ridouani, et al.. (2021). Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. HPB. 24(3). 404–412. 5 indexed citations
11.
Ridouani, Fourat, R. Michael Tuttle, Mario Ghosn, et al.. (2021). Ultrasound-Guided Percutaneous Laser Ablation of the Thyroid Gland in a Swine Model: Comparison of Ablation Parameters and Ablation Zone Dimensions.. CardioVascular and Interventional Radiology. 44(11). 1798–1806. 5 indexed citations
12.
Ridouani, Fourat, Mario Ghosn, F. Cornélis, et al.. (2021). Ablation Zone Involution of Liver Tumors Is Faster in Patients Treated with Irreversible Electroporation Than Microwave Ablation. Medicina. 57(9). 877–877. 5 indexed citations
13.
Ronot, Maxime, Mario Ghosn, Julien Caldéraro, et al.. (2020). Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma. European Radiology. 31(5). 3417–3426. 23 indexed citations
14.
Ghosn, Mario, Heather Wachtel, Douglas L. Fraker, et al.. (2017). Lateralization index but not contralateral suppression at adrenal vein sampling predicts improvement in blood pressure after adrenalectomy for primary aldosteronism. Journal of Human Hypertension. 31(7). 444–449. 16 indexed citations
15.
16.
Rougier, P, Mario Ghosn, G. Piot, et al.. (1992). Phase II Trial of 7-Day Continuous 5-Fluorouracil Infusion in the Treatment of Advanced Colorectal Carcinoma. Oncology. 49(1). 35–39. 8 indexed citations
17.
Droz, Jean‐Pierre, J. L. Pico, Mario Ghosn, et al.. (1991). Long-term survivors after salvage high dose chemotherapy with bone marrow rescue in refractory germ cell cancer. European Journal of Cancer and Clinical Oncology. 27(7). 831–835. 36 indexed citations
18.
19.
Piot, G., Jean‐Pierre Droz, C Théodore, et al.. (1988). Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma. Oncology. 45(5). 371–372. 1 indexed citations
20.
Ghosn, Mario, J P Droz, Christine Théodore, et al.. (1988). Salvage chemotherapy in refractory germ cell tumors with etoposide (vp-16) plus ifosfamide plus high-dose cisplatin. A vihp regimen. Cancer. 62(1). 24–27. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Théodore Breakdown of academic impact, for papers by Jonathan Rock Breakdown of academic impact, for papers by Pedro de Agustín Breakdown of academic impact, for papers by H Schefer Breakdown of academic impact, for papers by Claudio Graiff Breakdown of academic impact, for papers by Rei Noguchi Breakdown of academic impact, for papers by Subhash C. Gulati Breakdown of academic impact, for papers by Shinsuke Shibuya Breakdown of academic impact, for papers by Vogelzang Nj Breakdown of academic impact, for papers by Atsushi Iida
Rankless by CCL
2026